Document is current
Any future updates will be listed below
-
Authors
Duran, Ivan
Banerjee, Ankita
Flaherty, Patrick J.
Que, Yok-Ai
Ryan, Colleen M.
Rahme, Laurence G.
Tsurumi, Amy http://orcid.org/0000-0001-7678-169X
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (R03 AI151499, R56 AI155505)
- License Information
-
More Information
Article History
Received: 4 March 2024
Accepted: 9 August 2024
First Online: 28 August 2024
Declarations
:
: Consent to participate was not required, as this study entailed analyzing data from the Glue Grant (“Inflammation and Host Response to Injury”) cohort and did not enroll new patients. Permission for the secondary analysis of de-identified data was obtained from the Massachusetts General Hospital Institutional Review Board (MGH IRB protocol 2002P001743).
: ID, AB, PJF, YQ, CMR, AT report no conflict of interest. LGR has a financial interest in Spero Therapeutics.
